Mabel Vidal
Biographic Data
| ID | 8416499 |
|---|---|
| NAME | Mabel Vidal |
| GIVEN NAMES | Mabel |
| FAMILY NAME | Vidal |
| SIGNATURE | VIDAL M |
| AFFILIATIONS | Universidad de Santiago de Chile |
| ORCID | 0000-0002-0800-1353 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for Sars-CoV-2 in Santiago of Chile
Introduction: As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. …
Description of Symptoms Caused by the Infection of the Sars-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme
Vaccine administration is one of the most efficient ways to control the current coronavirus disease 2019 (COVID-19) pandemic. However, the appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can avoid the immunity generated by vaccines. Thus, in patients with a complete vaccine schedule, the infection by SARS-CoV-2 may cause severe, mild, and asymptomatic manifestations of the disease. In this case report, we descr…
No prominent works on this page.
Description of Symptoms Caused by the Infection of the Sars-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme
Vaccine administration is one of the most efficient ways to control the current coronavirus disease 2019 (COVID-19) pandemic. However, the appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can avoid the immunity generated by vaccines. Thus, in patients with a complete vaccine schedule, the infection by SARS-CoV-2 may cause severe, mild, and asymptomatic manifestations of the disease. In this case report, we descr…
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for Sars-CoV-2 in Santiago of Chile
Introduction: As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. …
Disease (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pandemic (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · 2019-20 coronavirus outbreak (1 work) · Asymptomatic (1 work) · Biology (1 work) · Computational biology (1 work) · COVID-19 Clinical Research Studies (1 work)